Acadia Pharmaceuticals, Inc. (ACAD) Reports In-Line Q1 Loss

May 7, 2013 4:02 PM

Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) reported Q1 EPS of ($0.08) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found